top of page


Managing Partner of Global BioAccess Fund, Ted holds over 20 years of global banking, strategic investment, business development, and law experience in healthcare and life science sectors.


Ted has significant cross border experience, especially in managing projects and facilitating investments in U.S., Israel and Korean companies. Ted has accumulated his track record by completing numerous innovative life sciences transactions including over $2 billion in strategic transactions and over $400 million in private funding for start-ups. He has been advising emerging biopharma/medtech venture companies as well as large corporations on their financial and strategic transactions including M&A, capital raising, strategic partnerships, and exit strategies including IPOs. Ted’s clients include large corporate groups such as Samsung, AmorePacific Group on their mergers and acquisition matters and strategic investments.


He is a managing partner of an early stage biopharma focused fund, RMGP Biopharma Investment Fund, which is investing in innovative biopharma ventures in Israel in collaboration with four global biopharma leaders i.e., J&J, Takeda Pharma, Bayer and OrbiMed.


Ted received both a Bachelor of Arts in Business Administration and an MBA from Kyung Hee University (Seoul). He also earned an MBA from George Washington University and a J.D. from Temple University School of Law.

bottom of page